EUVIMEDEUVIMED entdecken
Crossref

Clinical difference on the variants and co-mutation in a Chinese cohort with ALK-positive advanced non-small cell lung cancer

Ying Fu, Qing Liu, Xiaohan Wang, Liangchao Sun, Xiao Han, Xue Meng

Clinical and Translational Oncology · 2024

DOI: 10.1007/s12094-024-03481-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Oncology, 2024. Verfasst von Ying Fu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Mutation, Anaplastic Lymphoma Kinase. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Medical and Health Science and Technology Development Project of Shandong Province, Innovative Research Group Project of the National Natural Science Foundation of China, Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsMutationAnaplastic Lymphoma KinaseOncogene Proteins, FusionHumansMaleFemaleMiddle AgedRetrospective StudiesAgedAdultTumor Suppressor Protein p53Progression-Free SurvivalPrognosisChinaEast Asian People

Stichwörter der Autor:innen

ALK inhibitionEML4-ALKLong variantsNon-EML4-ALKTP53

Substanzen

Anaplastic Lymphoma KinaseOncogene Proteins, FusionEML4-ALK fusion protein, humanALK protein, humanTumor Suppressor Protein p53TP53 protein, human

Autor:innen und Institutionen

  • School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, China.
  • Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
  • Department of Oncology, Changqing District People's Hospital, Jinan, Shandong, China.
  • Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China. hxzbb1983@163.com.
  • Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China. mengxuesdzl@163.com.

Förderung

  • Medical and Health Science and Technology Development Project of Shandong Province
  • Innovative Research Group Project of the National Natural Science Foundation of China
  • Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province of China

Zitieren

APA

Fu, Y., Liu, Q., Wang, X., Sun, L., Han, X., & Meng, X. (2024). Clinical difference on the variants and co-mutation in a Chinese cohort with ALK-positive advanced non-small cell lung cancer. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-024-03481-w

Vancouver

Fu Y, Liu Q, Wang X, Sun L, Han X, Meng X. Clinical difference on the variants and co-mutation in a Chinese cohort with ALK-positive advanced non-small cell lung cancer. Clinical and Translational Oncology. 2024. doi:10.1007/s12094-024-03481-w

BibTeX
@article{Fu2024,
  author = {Fu, Ying and Liu, Qing and Wang, Xiaohan and Sun, Liangchao and Han, Xiao and Meng, Xue},
  title = {Clinical difference on the variants and co-mutation in a Chinese cohort with ALK-positive advanced non-small cell lung cancer},
  journal = {Clinical and Translational Oncology},
  year = {2024},
  doi = {10.1007/s12094-024-03481-w}
}
Kostenlos starten →